199 related articles for article (PubMed ID: 17122282)
21. Anesthetic management of a surgical patient with cardiac implantable electrical device.
Ramachandran S; Janelle G; Aleong R; Berger J; Krumerman A; McKillop M; Weitzel N
Semin Cardiothorac Vasc Anesth; 2012 Sep; 16(3):166-75. PubMed ID: 22913888
[No Abstract] [Full Text] [Related]
22. Electrosurgery and implantable electronic devices: review and implications for office-based procedures.
Voutsalath MA; Bichakjian CK; Pelosi F; Blum D; Johnson TM; Farrehi PM
Dermatol Surg; 2011 Jul; 37(7):889-99. PubMed ID: 21585593
[No Abstract] [Full Text] [Related]
23. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
Kay GN; Bittner GT
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
[No Abstract] [Full Text] [Related]
24. Management of implanted cardiac defibrillators during eye surgery.
Bayes J
Anesth Analg; 2008 Feb; 106(2):671; author reply 671-2. PubMed ID: 18227338
[No Abstract] [Full Text] [Related]
25. [Cardiac Pacemakers, implantable defibrillators and IRM].
Frank R; Hidden-Lucet F; Himbert C; Petitot JC; Fontaine G
Arch Mal Coeur Vaiss; 2003 Apr; 96 Spec No 3():46-9. PubMed ID: 12741332
[TBL] [Abstract][Full Text] [Related]
26. Obtaining rapid and effective hemostasis: Part II. Electrosurgery in patients with implantable cardiac devices.
Howe N; Cherpelis B
J Am Acad Dermatol; 2013 Nov; 69(5):677.e1-677.e9. PubMed ID: 24124835
[TBL] [Abstract][Full Text] [Related]
27. [Remote monitoring of automatic implantable cardiovascular devices (pacemakers, implantable cardioverter defibrillator and cardiac resynchronization)].
Guevara-Valdivia ME
Arch Cardiol Mex; 2009; 79(3):221-5. PubMed ID: 19902671
[TBL] [Abstract][Full Text] [Related]
28. [Training requirements for transvenous implantation of pacemakers and cardioverter-defibrillators].
Hemmer W; Rybak K; Markewitz A; Israel C; Krämer LI; Neuzner J; Nowak B; Pfeiffer D; Schuchert A; Wiegand U
Thorac Cardiovasc Surg; 2009 Feb; 57(1):1-10. PubMed ID: 19169987
[TBL] [Abstract][Full Text] [Related]
29. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
McDowell DL; Hauptman PJ
J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
[TBL] [Abstract][Full Text] [Related]
30. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.
Uslan DZ; Sohail MR; St Sauver JL; Friedman PA; Hayes DL; Stoner SM; Wilson WR; Steckelberg JM; Baddour LM
Arch Intern Med; 2007 Apr; 167(7):669-75. PubMed ID: 17420425
[TBL] [Abstract][Full Text] [Related]
31. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
[No Abstract] [Full Text] [Related]
32. Time for green pacemakers: renewable energy sources to power implanted cardiac devices.
Roberts PR
Expert Rev Med Devices; 2009 Nov; 6(6):597-8. PubMed ID: 19911869
[No Abstract] [Full Text] [Related]
33. Implanted electronic devices at endoscopy: advice in a gray area.
Petersen BT
Gastrointest Endosc; 2007 Apr; 65(4):569-70. PubMed ID: 17383454
[No Abstract] [Full Text] [Related]
34. Interference of neodymium magnets with cardiac pacemakers and implantable cardioverter-defibrillators: an in vitro study.
Ryf S; Wolber T; Duru F; Luechinger R
Technol Health Care; 2008; 16(1):13-8. PubMed ID: 18334784
[TBL] [Abstract][Full Text] [Related]
35. Electrosurgery, pacemakers and ICDs: a survey of precautions and complications experienced by cutaneous surgeons.
El-Gamal HM; Dufresne RG; Saddler K
Dermatol Surg; 2001 Apr; 27(4):385-90. PubMed ID: 11298712
[TBL] [Abstract][Full Text] [Related]
36. Electrosurgery and ultrasonics on patients with implantable cardiac devices: Evidence of side effects in the dental practice.
Pisano P; Mazzola JG; Tassiopoulos A; Romanos GE
Quintessence Int; 2016 Feb; 47(2):151-60. PubMed ID: 26811847
[TBL] [Abstract][Full Text] [Related]
37. Survey of cardiac rhythm management and device implant patterns in Puerto Rico: analysis of 13,854 cardiac implants.
Aranda JM; Girod M; Ochoa F; Abreu M; Rivera JJ; Sotomonte JC; Rodríguez A; Arzola D; Fiménez R; Aranda JM
Bol Asoc Med P R; 2008; 100(1):39-49. PubMed ID: 18763396
[TBL] [Abstract][Full Text] [Related]
38. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.
Klug D; Balde M; Pavin D; Hidden-Lucet F; Clementy J; Sadoul N; Rey JL; Lande G; Lazarus A; Victor J; Barnay C; Grandbastien B; Kacet S;
Circulation; 2007 Sep; 116(12):1349-55. PubMed ID: 17724263
[TBL] [Abstract][Full Text] [Related]
39. [A scientific journey: electromagnetic fields, cardiac pacemakers and defibrillators].
Souques M
Arch Mal Coeur Vaiss; 2003 Apr; 96 Spec No 3():3-4. PubMed ID: 12741324
[No Abstract] [Full Text] [Related]
40. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]